Taiko Pharmaceutical: Confirmation letter
Taiko Pharmaceutical: Quarterly Report - 79th Quarter 1 (2024/01/01 to 2024/03/31)
Taiko Pharmaceutical: Consolidated financial results report for the 1st quarter of the fiscal year ending 2024/12 (FY2024)
Taiko Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)
Taiko Pharmaceutical: Extraordinary Report
Taiko Pharmaceutical: Confirmation
Taiko Pharmaceutical: Financial Report - 78th Term (2023/01/01 - 2023/12/31)
Taiko Pharmaceutical: Notice Concerning the Recording of Special Profit and Revision of Consolidated Earnings Forecasts
Taiko Pharmaceutical: Consolidated financial results report for the fiscal year ending 2023/12 (FY2023)
Taiko Pharmaceutical: Extraordinary Report
Taiko Pharmaceutical: Notice regarding the recording of extraordinary loss (impairment loss) and the difference between consolidated earnings forecasts and actual values
Taiko Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending 2023/12 [Japanese GAAP] (Consolidated)
Taiko Pharmaceutical: Confirmation letter
Taiko Pharmaceutical: Quarterly Report - 78th Third Quarter (2023/07/01 - 2023/09/30)
Taiko Pharmaceutical: Notice regarding revisions to full-year earnings forecasts and dividend forecasts
Taiko Pharmaceutical: Consolidated Financial Report for the 3rd Quarter Ending 2023/12 (FY2023)
Taiko Pharmaceutical: Summary of Financial Results for the 3rd Quarter Ending December 31, 2023 [Japanese GAAP] (Consolidated)
Taiko Pharmaceutical: Consolidated financial results report for the 2nd quarter of the fiscal year ending 2023/12 (FY2023)
Taiko Pharmaceutical: Confirmation letter
Taiko Pharmaceutical: Quarterly Report - Q78 2nd Quarter (2023/04/01 - 2023/06/30)
No Data